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Abstract: Lichen planus (LP) is a chronic T-cell-
mediated mucocutaneous inflammatory disease that 
targets stratified epithelia, including those lining the 
oral cavity. The intraoral variant of LP (OLP) is associ-
ated with interferon (IFN)-γ production by 
infiltrating T lymphocytes; however, the role of 
epithelial cells in the etiopathogenesis OLP is not 
completely understood. There is however a growing 
body of evidence regarding the involvement of 
epithelial-derived cytokines, immune receptors, and 
costimulatory molecules in the pathobiological 
processes that promote and sustain OLP. In the 
present study, we used a reverse transcriptase-
polymerase chain reaction assay to assess whether 
CD40—a receptor found mainly on antigen 
presenting cells—and the costimulatory molecule 
CD86 were expressed in oral keratinocytes (three 
strains of primary normal oral keratinocytes and the 
H357 cell line) in the presence or absence of IFN-γ. 
To further characterize the involvement of CD40 in 
OLP, expression and distribution of receptor and 
ligand (CD40/CD154) in tissues from OLP were 
evaluated by immunohistochemistry. The present 
results are the first to show that both CD40 and 
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CD86 are constitutively expressed at low levels in 
oral keratinocytes and that their expression was 
enhanced by IFN-γ stimulation. The intensity of CD40 
staining in OLP tissues was strong. Taken together, 
the results strongly suggest that CD40 and CD86 play 
a role in the pathophysiology of oral inflammatory 
diseases such as OLP. 
Keywords: CD40; CD86; oral lichen planus; oral 
inflammation; regulatory T-cells; mucosa. 
Introduction 
Lichen planus (LP) is a chronic T-cell-mediated muco-
cutaneous inflammatory disease whose etiology and 
pathogenesis are not completely understood. To 
clarify the pathological regulatory mechanisms 
associated with LP, we investigated expressions of 
CD40 and CD86 in oral keratinocytes and their role in 
inflammatory disease of the oral cavity. 
CD40 is a 45-50 kDa phosphorylated type I integral 
membrane glycoprotein that belongs to the tumor 
necrosis factor receptor superfamily, which is 
expressed on various hematopoietic and non-
hematopoietic cells (1-11). CD40 is involved in several 
biological functions, such as cell-mediated immunity 
and cell growth regulation. The ligand for CD40 is 
CD154, also known as CD40 ligand (CD40L), a cell 
surface molecule mainly expressed by activated T-
cells. Through interaction with its receptor, CD154 is 
pivotal in T-cell-dependent humoral response and 
cell-mediated immunity and 
 375 
inflammation. Thus, it is a key element in the 
pathogenic process of chronic inflammatory diseases 
and autoimmune disorders and has additional 
implications for the many pathogenic steps of 
tumorigenesis (10,12,13). 
Interferon (IFN)-γ increases CD40 expression in a 
number of epithelial cell lines, including buccal oral 
epithelium (1,7). CD40 expression increases after 
proinflammatory cytokine treatment; thus, it is not 
surprising that CD40 epithelium expression is 
enhanced in some inflammatory conditions (4). 
In oral epithelium, CD40 is involved in many aspects 
of cell homeostasis, as it is constitutively expressed by 
oral keratinocytes and can stimulate T lymphocytes by 
reacting further with several costimulatory molecules, 
including B7.2 (or CD86), one of the most important 
B7 molecule family members (14). CD86 can bind to 
the ligand CD28 or cytotoxic T-lymphocyte-associated 
molecule-4 (CTLA-4), located on resting and activated 
T-cells, thus determining respective upregulation of T-
cell stimulation and clonal expansion via multiple 
cytokines stimulation, or downregulation of this 
process (15,16). 
Increasing evidence indicates that CD40 expression on 
epithelium plays a role in immune response by stimu-
lating production of cytokines and chemokines. 
Previous studies reported that these chemokines are 
upregulated in oral lichen planus (OLP) and that OLP is 
characterized by large numbers of activated T-cells 
localized near the epithelium or infiltrating basal 
epithelium (7,9). 
This study investigated the effect of IFN-γ treatment 
on CD40 mRNA expression in oral epithelial cells. 
Antigen presentation by keratinocytes is believed to 
have a role in OLP pathogenesis, and data on CD86 
expression are inconsistent (1,17-24). Thus, we 
investigated CD86 mRNA expression in oral epithelial 
cells because of its crucial role in this process. In 
addition, to characterize CD40-CD154 cell expression 
and distribution, CD40/ CD154 were additionally 
evaluated by immunohistochemistry in OLP tissue. 
The results are the first to show that CD40 and the 
costimulatory molecule CD86 are constitutively 
expressed at low levels in oral keratinocytes and that 
their expression is enhanced by IFN-γ stimulation. 
Materials and Methods 
Patients 
OLP tissue (n = 12) was collected from patients 
attending the Oral Medicine Clinic of Eastman Dental 
Institute or the Royal Dental Hospital of Melbourne. 
In all cases, the diagnosis of OLP was confirmed by a 
pathologist; patients with other systemic diseases 
were excluded. Normal oral mucosa was obtained 
from patients attending the Oral 
Surgery Clinic of Eastman Dental Institute for routine 
extraction of third molars. This study was approved by 
the internal Ethical Committee of the UCL Eastman 
Dental Institute and the University of Melbourne 
Human Research Ethics Committee in 2008 (0827052. 
1). 
Cell culture techniques 
Culture of normal human oral keratinocytes 
Normal oral mucosal tissue was obtained from 
healthy patients, and three normal human oral 
keratinocyte (NHOK) strains (NHOK1-3) were isolated 
by separating connective tissue from excised normal 
tissue. The samples were cut into approximately 1-
mm3 pieces and cultured at 37°C/5% CO2 in 
keratinocyte basal medium-2 containing the 
recommended growth supplements (Biowhittaker, 
Wokingham, UK). The epithelial cells were then 
detached using 0.25% trypsin-1 mM EDTA. The 
viability of the keratinocytes was confirmed by trypan 
blue exclusion. 
H357 cell culture 
The oral squamous cell carcinoma cell line H357 was 
established by Prime et al. (25) from a primary 
explant of a tongue squamous cell carcinoma. This cell 
line was grown in the same medium used for NHOK. 
CD40/CD86 reverse transcriptase-polymerase chain 
reaction 
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mRNA derived from H357 cells and primary oral 
epithelial cells treated with 1,000 U/mL IFN-γ for 48 h 
was investigated. Primers specific for human CD40 
mRNA and CD86 mRNA were generated for this 
reaction, namely, CD40 forward 5’-
CTGGGCTAGCGATACAGGAG-3’ and reverse 5’-
GGAATTTCTGTTGGCCAAATCCA-3’ and CD86 forward 
5’-AGACGCGGCTTTTATCTTCA-3’ and reverse 5’-
AACTCCAGCTCTGCTCCGTA-3’ (Genosys-Sigma, Poole, 
UK), and reverse transcriptasepolymerase chain 
reaction was performed. Magnesium concentration 
was optimized for each primer as follows: 1 μL of 
cDNA was added to 4 μL dNTP (2.5 mM), 5 μL 10× 
buffer, 0.225 μL AmpliTaq (5.0 U/μL) (Perkin Elmer, 
Wokingham, UK), 4 μL of each specific primer (5 μM), 
1.5, 3.0, or 4.5 mM MgCl in each reaction and dH2O, 
to yield a final volume of 50 μL. The thermocycler 
(Techne Genius; Cambridge, UK) parameters varied in 
relation to the primers used, and the annealing 
temperature of the reaction depended on the 
guanidine-cytosine content of the primers. The 
general parameters used were 94°C for 45 s, 
annealing temperature (57 to 60°C) for 45 s, and 72°C 
for 45 s, repeated for 35 cycles. 
The products were separated on a 2% agarose 
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(GibcoBRL Life Technologies, Paisley, UK) gel and 
visualized by ethidium bromide (Sigma, Poole, UK) 
staining. Specific bands were visualized by ultraviolet 
transillumination in a MultiImage Light Cabinet (Alpha 
Innotech Corp., Cannock, UK), and digital images were 
acquired and stored using AlphaImager Software 
(Alpha Innotech Corp.). The primers used for the 
study of housekeeping expression encoded a region 
of 18S ribosomal RNA (5’-TTTCGGAACTGAGGCCATGA-
3’, 5’-GCATGCCAGAGTCTCGTTCG-3’). 
IFN-γ cell treatment assay 
In a modification of the method described by 
Altenburg et al. (26), the primary oral epithelial cells 
and H357 cell line (at the second or third passage) 
were seeded at 8 × 104 cells/well in a Falcon 6-well 
plate (Becton Dickinson, Oxford, UK) with 3 mL of 
KBM-2 medium containing no hydrocortisone. The 
cells were incubated for at least 3-5 days until the cell 
culture was 60 to 80% confluent. We used dose-
response curves from preliminary experiments to 
determine the optimal experimental conditions. 
Medium containing 1,000 U/mL IFN-γ was added to 
three wells, and control cell culture medium only was 
added to the remaining three wells. The cells were 
incubated for 48 h or for 3, 6, 9, 24, 48, or 72 h for the 
H357 time course. The supernatant was extracted, 
centrifuged, and stored at −70°C. The adherent cells 
were washed with phosphate-buffered saline (Gibco 
Life Technologies, Paisley, UK) before the addition of 
0.5 mL of TriReagent (Sigma). The suspension was 
then removed and stored at −70°C. 
Immunohistochemical methods 
Paraffin section preparation 
Archival paraffin-embedded formalin-fixed (PEFF) OLP 
specimens were used. Normal non-diseased skin (leg) 
sections and oral mucosa (tonsil) sections were used 
as positive and negative control samples. A 
microtome was used to cut the paraffin blocks to a 
thickness of 4 μm, and the specimens were mounted 
on Superfrost Plus slides (Thermo Scientific, Paisley, 
UK). 
Antigen retrieval methods 
Sections were dewaxed with a xylene wash (BDH, 
Poole, England) followed by ethanol washes. The 
CD154 sections were boiled in citric acid on a hot 
plate for 20 min and cooled at room temperature for 
20 min; the CD40 sections were boiled in citric acid on 
hot plate for 10 min and cooled at room temperature 
for 20 min. Then the sections were washed in PBS, 
and the endogenous peroxidase was quenched with 
3% H2O2 in methanol for 
5 min. 
Antibodies for immunohistochemistry 
The primary antibodies were purified anti-human 
CD154 (C-20) antibody (sc-978, rabbit polyclonal IgG, 
Santa Cruz Biotechnology Inc., Dallas, TX, USA; diluted 
1:50 in PBS) and purified anti-human CD40TNFRSF5 
antibody (PA5-32325, rabbit polyclonal IgG, Thermo 
Fisher, Paisley, UK) diluted 1:50 in PBS. The secondary 
antibody was Biotinylated Universal (PK-6200, anti-
mouse IgG/rabbit IgG) antibody (Vectastain Universal, 
Elite, ABC kit, Vector Laboratories, Inc, Burlingame, 
CA, USA). 
3’, 3’-diaminobenzide staining and image acquisition 
The study slides containing OLP sections and positive 
control were incubated with the primary antibody for 
30 min at room temperature. The negative control 
was incubated with no primary antibody (PBS only) 
for the same time at room temperature. The slides 
were then washed in PBS three times and incubated 
with the secondary antibody for 30 min at room 
temperature. The slides were then incubated with 
Avidin DH/horse biotinylated horseradish peroxidase 
solution (Vectastain Universal, Elite, ABC kit, Vector 
Laboratories, Inc). The slides were washed three 
times with PBS, and 3’, 3’-diaminobenzide (DAB; Dako 
Australia Pty. Ltd, North Sydney, Australia) was 
applied for 5 min. After this, the slides were washed 
with PBS, counterstained in Mayer’s Hematoxylin 
(Amber Scientific, Midvale, Australia), and mounted. 
Consecutive sections of the same samples were also 
stained with hematoxylin and eosin without 
immunohistochemistry. Images were obtained by 
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using an Aperio CS2 Digital Pathology Slide Scanner 
(Leica Biosystems, Mount Waverley, Australia). 
Statistical analysis 
Statistical significance was determined with the 
unpaired t-test. 
Results 
Time course study of CD40/CD86 expression in H357 
cells treated with IFN-γ 
CD40/CD86 production in oral mucosal keratinocytes 
was first assessed over time in preliminary 
experiments using the keratinocyte cell line H357 (Fig. 
1). After 3 h of IFN-γ treatment, very low levels of 
CD40 mRNA and CD86 mRNA were detectable in 
H357 cells. After 
6 h, expressions of CD40 mRNA and CD86 mRNA 
were slightly higher in cells treated with IFN-γ than in 
the control cells. Interestingly, CD40 and CD86 mRNA 
 
Fig. 1 CD40/CD86 mRNA expression in H357 (time course). Fig. 2 a) Expression of 18S, CD40, and CD86 mRNA 
in three 
different normal human oral keratinocyte (NHOK; shown as 1, 2, and 3) lines after IFN-γ treatment (IFN-γ 1-3) for 
48 h and in untreated (CON 1-3) and negative controls (--). b) Values were normalized against 18S mRNA 
expression used as housekeeping. c) Triplicate average with standard deviation and statistical significance. **P ≤ 
0.01. 
Fig. 3 CD40 localisation in OLP tissue after peroxidase 
staining. Intense staining was associated with 
subepithelial band-like infiltrate. Epithelial cells within OLP lesions exhibit mild to moderate staining 
(magnification 4× and 20×). Negative control sections 
show no staining. Normal control and typical HE staining of OLP Fig. 4 CD40 localisation associated with 
inflammatory infiltrate 
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are shown in Supplementary Fig. 1. in OLP tissue. Staining is mostly present within dense inflamma- 
tory infiltrate and on cells near and infiltrating the epithelial layer (magnification 40×). 
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expression was virtually undetectable in control cells 
at 9 h. IFN-γ-treated cells had detectable CD86 mRNA 
levels up to 72 h, whereas CD86 mRNA transcripts 
were present for up to 48 h in control cells. Taken 
together, these finding indicate that CD40 and CD86 
expressions in H357 cells are enhanced by IFN-γ 
stimulation. 
Costimulatory molecule expression in oral 
epithelium in vitro 
CD40 was expressed constitutively in three primary 
oral epithelial cell lines but was increased by IFN-γ 
treatment in vitro (Fig. 2a, b). Statistical analysis 
revealed that mRNA expression was significantly 
higher (P < 0.001) in the IFN-γ group (0.853 ± 0.025) 
than in the control group (0.419 ± 0.0134) (Fig. 2c). 
The pattern was similar 
for the costimulatory molecule CD86 on the same cell 
lines. Constitutive CD86 expression was very low but 
increased after IFN-γ treatment, although the 
difference was not statistically significant (Fig. 2c). 
CD40/CD154 expression in OLP tissue 
In sections of OLP lesional tissue, concentrated CD40 
staining was associated with cells within OLP 
infiltrate, although staining of individual cells near the 
epithelium were visible, as was moderate epithelial 
staining (Fig. 3). Staining was particularly intense 
within band-like inflammatory infiltrate (Fig. 4). Cells 
in the basal area had relatively high expressions, 
although positive cells were also seen in the 
suprabasal area. Certain focal areas of the basal 
epithelium had particularly high expression 
 
Fig. 5 CD154 expression in oral lichen planus tissue 
(magnification 10× and 40×). Infiltrating cells near the 
basal epithelium exhibit anti-CD154-positive staining; 
the epithelium exhibits weak or no staining. 
levels. CD154 was expressed on infiltrating cells in 
OLP lesions but not within the epithelial layers (Fig. 5). 
Positive cells tended to be located near epithelial cells 
at the epithelial-connective tissue junction, especially 
in focal areas of cell damage. 
Discussion 
The intensity of CD40 staining in OLP was strong, 
particularly on cells within infiltrate, which may be 
CD40-positive Langerhans cells. In addition, CD40 
expression was seen in oral epithelial cells. CD40 
expression has been reported in other epithelial cell 
types in vivo and appears to increase during other 
inflammatory disorders. Furthermore, CD40 
expression was increased on primary oral 
keratinocytes after IFN-γ incubation in the present 
study, which is consistent with the findings of other 
studies (1). This cytokine may thus be important in 
the stimulation and inflammation of oral epithelium. 
Furthermore, CD86 mRNA expression was enhanced 
after IFN-γ treatment of oral keratinocytes, and the 
implications of this expression in oral inflammatory 
disease may be of great importance, as discussed 
below. 
Past and present findings suggest that CD40/CD86 
ligation is involved in inflammatory enhancement. In 
OLP, T-cells appear to be activated and thus are likely 
to express CD154 (27), the ligand for CD40. The 
proximity of infiltrating T-cells and epithelium in OLP, 
which sometimes facilitates interactions between T-
cells and epithelium, suggests CD40 and CD154 
ligation in OLP. This ligation induces or enhances 
multiple effects in epithelial cells, including increasing 
the production of proinflammatory cytokines (5,28) 
and chemokines (5,29-31). Increased production of 
these molecules in the epithelial area in OLP likely 
increases inflammation. Specifically, increased 
expression of CXC-ELR-chemokines in OLP is due in 
part to ligation of CD40 on oral epithelial cells, as was 
shown previously in cervical carcinoma cells (26). 
Furthermore, increased production of RANTES by 
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keratinocytes in OLP (32) might be influenced by CD40 
ligation (29,33). 
IFN-γ may also be important in inflammation of oral 
epithelium, as it can increase CD40 expression on 
epithelial cells and induce expression of chemokines 
such as CXCL10 (Marshall et al., manuscript in 
preparation). These mechanisms presumably promote 
migration into the area of activated T-cells, which may 
interact with epithelial cells and bind CD40. These 
effects would synergize to produce more chemokines 
and exacerbate the inflammatory status of conditions 
such as OLP (34-36). 
Induction of B7 molecules on keratinocytes increases 
immunogenicity to antigenic stimulants, which results 
in a large influx of stimulated T-cells. An increase in 
the delayed-type hypersensitivity response to 
reencountered antigens in B7 transgenic mice has 
many similarities to the pathogenic mechanisms of 
OLP, including the large T-cell influx visible in OLP and 
the chronic nature of the disease. CD86 is upregulated 
on oral epithelium by IFN-γ in vitro, and there are 
many features suggestive of IFN-γ stimulation on 
keratinocytes in OLP. These findings suggest that this 
molecule is expressed on cells involved in increased 
immunogenicity to antigens, including common oral 
commensals such as Candida. Furthermore, CD86 
expression on oral epithelium may be relevant to cell 
migration, as CD28 ligation of CD4+ cells can alter 
chemokine receptor expression (37). 
Although we have shown that CD86 is induced on oral 
epithelium in vitro, its expression in OLP is unknown. 
Simon et al. (38) investigated the expression of CD28 
and B7 in cutaneous LP lesions and found that the B7-
1 molecule was focally expressed on keratinocytes 
within the lesion. However, the antibody for B7-1 was 
also detected in the major histocompatibility complex 
(MHC) molecule (39), and we suspect that it was this 
molecule that was detected in LP. 
CTLA-4 and CD28 binding affect Th1/Th2 differen-
tiation but would appear to have a larger effect on 
naïve cells than on memory cell interactions (40), 
which occur in OLP. 
Because of the increase in costimulatory molecules in 
epithelium after inflammatory signals, including oral 
epithelial cells (as shown in this study), such 
molecules may act as nonprofessional antigen-
presenting cells in OLP (41). Keratinocytes have the 
genes necessary for antigen presentation (42); 
however, if oral keratinocytes were capable of 
antigen presentation, it would likely have to be 
immunogenic antigen presentation in OLP, to cause 
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the observed reaction. However, it has proven 
difficult to identify the factors that provide even 
professional antigen-presenting cells with tolerogenic 
or activating signals to T-cells in the periphery (43). 
Like bronchial and intestinal epithelium, oral epithe-
lium is capable of antigen presentation, although by 
other mechanisms (3,44-46). In particular, an increase 
in the expression of costimulatory molecules, e.g., 
during inflammation, is required for oral epithelial 
antigen presentation. It is possible that the antigens 
present at high doses—and thus more likely to elicit 
an effective T-cell response (16)—are those with 
persistently high levels in oral mucosa, such as betel 
nut antigens in chronic users and amalgam antigens 
of patients with these fittings. If these antigens were 
combined with inflammatory signals, active antigen 
presentation of these antigens might yield an 
immunogenic rather than tolerogenic response. 
Proposed activation/tolerance theories regarding 
dendritic cells—i.e., that stimulatory function is either 
enhanced by toll-like receptors on dendritic cells 
recognizing microbial products and upregulating 
costimulatory molecules (47) or that damage in other 
cells and production of molecules such as heat shock 
proteins act as “danger signals” (48) that activate 
dendritic cells—may also be true for epithelial cells 
(49-52). 
Induction of costimulatory molecules on the 
epithelium does not result in T-cell activation, as 
these molecules may actually bind to CTLA-4, which is 
thought to be important in providing tolerance (53). 
In fact, dysregulation of CTLA-4 in OLP patients may 
be responsible for a breakdown in tolerance for oral 
keratinocyte antigens (54). Although CTLA-4 cells 
were clearly expressed in most samples of cutaneous 
LP tissue, there was no such expression in a variety of 
other skin inflammatory disorders (55). The 
implications of this finding are unclear; however, the 
fact that many infiltrating T-cells in LP express CD28 
(38) suggests that these cells interact with CD86-
expressing keratinocytes, thereby leading to specific 
clonal activation of these cells (56). 
A subset of CD4+ T-cells that express CD25 represents 
regulatory T-cells that might be involved in the 
suppression of autoimmunity (57-59). Interestingly, 
CD25+ cells are upregulated in OLP (58). However, 
these cells are also thought to involved in infection 
persistence, perhaps in order to permit long-term 
immunity (57). Therefore, these cells might be 
important in disease chronicity in persons with low-
level (or undetectable) infection. OLP chronicity and 
the presence of CD25+ cells may therefore be related. 
If oral keratinocytes are capable of antigen presenta-
tion, it would be nonprofessional antigen 
presentation, i.e., the cells would be unable to 
migrate to lymph nodes to stimulate naïve T-cells. 
This suggests that it is predominately memory cells 
that are activated in this manner. In fact, memory T-
cells are activated by a range of different antigen-
presenting cells and require less costimulatory 
function than do naïve cells (60). Interestingly, most 
infiltrating cells in OLP lesions are memory T-cells. 
Furthermore, the possible increase in chemokine 
production by T-cell ligation of keratinocytes in OLP 
would likely promote further migration of memory 
cells into this area. This suggests that Langerhans cells 
are important in initiating naïve T-cell responses, 
whereas, in secondary response, keratinocytes may 
play a role in reactivating memory T-cell responses. 
However, resident tissue APCs are implicated in 
presenting self-antigen to Th1 cells in autoimmune 
conditions (61); thus, keratinocytes may also play a 
role in initiating the presentation process to Th1 cells. 
The reaction against oral keratinocytes in OLP 
suggests a failure in tolerance to self-antigens of oral 
epithelial cells. A number of mechanisms could affect 
this potential breakdown of self-tolerance in oral 
mucosa, including molecular mimicry (62) and epitope 
spreading (63). 
Because of the number of agents associated with OLP 
onset and chronicity, which may be caused by the 
different shift of epitopes detected in the disease, 
epitope spreading is a possible pathogenetic 
mechanism of this disease. Furthermore, CD80/86 
blockade (64) or CD40-CD154 blockade (65) inhibits 
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epitope spreading and eases ongoing autoimmunity in 
animal models. The fact that CTLA-4+ve cells enable 
epitope spreading (54) suggests that CD25+ cells 
observed in OLP may down-regulate immune 
reaction. However, further epitope changes might 
promote a wave of inflammatory T-cells. Epitope 
spreading is implicated in chronic diseases like 
multiple sclerosis, which exhibit relapse and 
remission. Therefore, this pathogenicpattern might be 
present in OLP. 
Despite the large number of CD4+ cells present in 
lesions, CD8+ cells are localized near the epithelial 
area in OLP. This suggests the presence of MHC class I 
restricted presentation within OLP lesions. However, 
it may be that prior class II presentation by 
keratinocytes assists in initiating a cytotoxic T 
lymphocyte reaction. Interestingly, CD40 ligation of 
antigen-presenting cells is important in the 
generation of cytotoxic T lymphocytes (66, 67). 
Therefore, if keratinocytes are presenting antigen 
through the MHC class II pathway, ligation of CD40, 
which is classically associated with antibody-mediated 
reactions, may amplify inflammation in the area and 
facilitate induction of specific cytotoxic T 
lymphocytes. 
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A group of CD8+ effector memory cells is preferen-
tially located in non-lymphoid tissue. These cells 
rapidly expand after activation (68) and thus may not 
require further T helper cells. Furthermore, CD8+ 
memory cells have a limited requirement for B7 
costimulatory signals. However, because autoreactive 
CD4+ and CD8+ T-cells often have a weaker affinity to 
antigen, they may require B7 stimulation (40). Thus, 
expression on oral epithelium may still be relevant. 
The process of cross-tolerance (69) is thought to be 
important in acquiring self-tolerance to apoptotic 
cells. In fact, there is a subset of intestinal dendritic 
cells that transports apoptotic epithelial cells to lymph 
nodes (70), a process thought to provide exposure 
and induction of tolerance to “self” antigen. 
Furthermore, Langerhans cells are capable of 
phagocytosis of vaginal apoptotic epithelial cells (71). 
These findings are of particular interest, as it is 
thought that apoptotic keratinocytes are present in 
OLP (9). Transport of antigen from these cells to 
lymph nodes may induce an immunogenic response 
to these antigens instead of a tolerizing effect (72). 
This process might produce T-cells autoreactive to 
keratinocytes. Additionally, ligation of CD40 on 
epithelial cells causes growth inhibition and increases 
apoptosis of cells in ovarian carcinoma cell lines (5). 
This finding is of interest because of increased 
apoptosis of this cell type in OLP (in conjunction with 
associated CD40 expression). This may induce 
transport of apoptotic cells to lymph nodes for cross-
presentation, a process that was found to be age-
related (73). 
Molecular mimicry and epitope spreading is thought 
to occur in class I restricted antigens and in class II 
antigens, so it may have an effect on direct MHC class 
I presentation, thereby exerting a cytotoxic effect in 
OLP. 
Accumulating evidence regarding the presence of 
molecules on epithelial cells suggests that they may 
sometimes be capable of antigen presentation. 
Whether this antigen presentation produces a 
tolerogenic or immunogenic response is unknown, 
although the presence of MHC-II and CD40, potential 
CD86 expression on oral epithelial cells, and CD28 in 
T-cell infiltrate of OLP suggests that “activating” 
antigen presentation might occur. Antigen 
presentation may take the form of “sampling” 
antigens on oral mucosa, such as bacterial antigens. 
The implications for antigen presentation may be very 
important in conditions such as OLP, as there appears 
to be a breakdown in tolerance for “self” keratinocyte 
antigens. This breakdown could be caused by a 
number of mechanisms, including molecular mimicry 
or epitope spreading. However, CD8+ cells appear to 
be acting cytotoxically in OLP; therefore, the class I 
pathway may be more important in the disease 
process. The presence of inflammatory signals during 
cross-presentation of apoptotic keratinocytes might 
cause normal tolerogenic CD8+ cells to become 
autoreactive for these cells. Interestingly, ligation of 
CD40 on keratinocytes (which is expressed in OLP) is 
thought to cause apoptosis of this cell type. 
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